• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻二酚油治疗耐药性癫痫儿童的长期有效性和安全性。

The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy.

机构信息

Pediatric Neurology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Pediatric Neurology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Pediatr Neurol. 2022 Nov;136:15-19. doi: 10.1016/j.pediatrneurol.2022.06.016. Epub 2022 Jun 28.

DOI:10.1016/j.pediatrneurol.2022.06.016
PMID:36049378
Abstract

BACKGROUND

Several retrospective studies on pediatric epilepsy reported positive effects of cannabidiol-enriched artisanal cannabis oil and pure cannabidiol oil on seizure reduction.

METHODS

This is a retrospective study of children and adolescents with refractory epilepsy caused by various etiologies who were treated with artisanal cannabis oil during January 2014 to June 2019, with at least one year follow-up.

RESULTS

Of 114 patients, 84 (73.3%) reported some improvement in seizure frequency at some point during treatment. Fifty-one (59%) of the 86 patients who continued treatment for at least one year showed >50% improvement in seizure frequency. Seizure etiology, seizure type, and patients' age and sex were not found to be associated with the response to cannabidiol-enriched cannabis oil. Side effects were minor, and positive effects beyond seizure reduction were noted.

CONCLUSIONS

Artisanal cannabidiol-enriched cannabis may be an effective and safe long-term treatment for refractory epilepsy.

摘要

背景

几项针对儿科癫痫的回顾性研究报告称,富含大麻二酚的手工大麻油和纯大麻二酚油对减少癫痫发作有积极影响。

方法

这是一项回顾性研究,纳入了在 2014 年 1 月至 2019 年 6 月期间接受手工大麻油治疗的、由各种病因引起的难治性癫痫的儿童和青少年患者,所有患者均至少随访了 1 年。

结果

114 例患者中,有 84 例(73.3%)在治疗过程中的某个时间点报告癫痫发作频率有所改善。86 例至少持续治疗 1 年的患者中有 51 例(59%)癫痫发作频率改善超过 50%。癫痫病因、癫痫类型以及患者的年龄和性别与对富含大麻二酚的大麻油的反应无相关性。副作用较小,且观察到了除减少癫痫发作以外的积极效果。

结论

手工制作的富含大麻二酚的大麻可能是治疗难治性癫痫的一种有效且安全的长期治疗方法。

相似文献

1
The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy.大麻二酚油治疗耐药性癫痫儿童的长期有效性和安全性。
Pediatr Neurol. 2022 Nov;136:15-19. doi: 10.1016/j.pediatrneurol.2022.06.016. Epub 2022 Jun 28.
2
Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?富含大麻二酚的油治疗耐药性癫痫:是否存在耐受性?
Brain Dev. 2021 Jan;43(1):89-96. doi: 10.1016/j.braindev.2020.06.018. Epub 2020 Jul 24.
3
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.大麻二酚手工制剂治疗癫痫的疗效:三级医疗中心的实践经验。
Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9.
4
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.富含大麻二酚的大麻提取物治疗小儿癫痫的感知疗效:对婴儿痉挛症和伦诺克斯-加斯托综合征的潜在作用。
Epilepsy Behav. 2015 Jun;47:138-41. doi: 10.1016/j.yebeh.2015.04.009. Epub 2015 Apr 29.
5
Second-line cannabis therapy in patients with epilepsy.二线大麻治疗癫痫患者。
Clin Neurol Neurosurg. 2023 Apr;227:107638. doi: 10.1016/j.clineuro.2023.107638. Epub 2023 Feb 21.
6
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.儿童治疗抵抗性癫痫中使用富含大麻二酚的大麻的家长调查报告。
Epilepsy Behav. 2013 Dec;29(3):574-7. doi: 10.1016/j.yebeh.2013.08.037.
7
The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.难治性癫痫性脑病患儿大麻二酚(CARE-E)研究方案:一项1期剂量递增研究。
BMC Pediatr. 2018 Jul 7;18(1):221. doi: 10.1186/s12887-018-1191-y.
8
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.大麻二酚治疗耐药性癫痫患者:一项开放标签的干预性试验。
Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24.
9
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.富含大麻二酚的医用大麻治疗儿童和青少年难治性癫痫的疗效——一项观察性纵向研究。
Brain Dev. 2018 Aug;40(7):544-551. doi: 10.1016/j.braindev.2018.03.013. Epub 2018 Apr 16.
10
Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy.前瞻性队列研究:长期使用富含大麻二酚的医用大麻治疗耐药性发育性和癫痫性脑病。
Seizure. 2022 Feb;95:56-63. doi: 10.1016/j.seizure.2022.01.001. Epub 2022 Jan 4.

引用本文的文献

1
Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis.大麻二酚辅助治疗耐药性癫痫的长期疗效及不良反应:一项系统评价与荟萃分析
Ther Adv Neurol Disord. 2023 Oct 30;16:17562864231207755. doi: 10.1177/17562864231207755. eCollection 2023.